Canadian application, no grantCanada
Biologically active materials
CA 2374548 A1 · Owner: Ml Laboratories Plc · Inventors: Duncan, Ruth; Hreczuk-Hirst, Dale; German, Lisa
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a polymer drug conjugate for the treatment of cancer comprising a succinoylated dextrin wherein said succinoylation enhances the in vivo stability of said conjugate.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 19, 2000
GrantedNo grant recorded
Term endedJune 19, 2020
Patent numberCA 2374548 A1
Classification (IPC)A61K47/48 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.